# Chinese Academy of Medical Sciences & Peking Union Medical College **Type:** Institutions **Canonical URL:** https://scholariq.org/institutions/chinese-academy-of-medical-sciences-and-peking-union-medical-college/ ## Facts | Field | Value | | --- | --- | | Avg h-index | 53.8 | | Citations | 17,821,155 | | City | Beijing | | Country | CN | | Description | Chinese Academy of Medical Sciences & Peking Union Medical College is a research organisation in Beijing, CN. OpenAlex records 198,676 works and 17,821,155 citations for it. 70,451 researchers list it as their most recent affiliation. | | Homepage | http://www.cams.ac.cn/ | | OpenAlex ID | https://openalex.org/I200296433 | | Region | Beijing | | Researchers | 70,451 | | ROR ID | https://ror.org/02drdmm93 | | Type | education | | Works | 198,676 | ## University papers Showing 12 of 463. - [Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study](https://scholariq.org/papers/clinical-course-and-risk-factors-for-mortality-of-adult-inpatients-with-covid-19/) - [ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data](https://scholariq.org/papers/annovar-functional-annotation-of-genetic-variants-from-high-throughput/) - [Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries](https://scholariq.org/papers/global-surveillance-of-trends-in-cancer-survival-2000-14-concord-3-analysis-of/) - [A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19](https://scholariq.org/papers/a-trial-of-lopinavir-ritonavir-in-adults-hospitalized-with-severe-covid-19/) - [Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies](https://scholariq.org/papers/detection-of-circulating-tumor-dna-in-early-and-late-stage-human-malignancies/) - [Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK](https://scholariq.org/papers/safety-and-efficacy-of-the-chadox1-ncov-19-vaccine-azd1222-against-sars-cov-2-an/) - [A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity](https://scholariq.org/papers/a-common-variant-in-the-i-fto-i-gene-is-associated-with-body-mass-index-and/) - [Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study](https://scholariq.org/papers/erlotinib-versus-chemotherapy-as-first-line-treatment-for-patients-with-advanced/) - [Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017](https://scholariq.org/papers/mortality-morbidity-and-risk-factors-in-china-and-its-provinces-1990-2017-a/) - [Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial](https://scholariq.org/papers/remdesivir-in-adults-with-severe-covid-19-a-randomised-double-blind-placebo/) - [Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer: 2006–2008](https://scholariq.org/papers/saving-mothers-lives-reviewing-maternal-deaths-to-make-motherhood-safer-2006/) - [Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial](https://scholariq.org/papers/safety-and-immunogenicity-of-the-chadox1-ncov-19-vaccine-against-sars-cov-2-a/) ## University researchers Showing 15 of 33. - [Jiang Liu](https://scholariq.org/researchers/jiang-liu/) - [Yan Wang](https://scholariq.org/researchers/yan-wang/) - [Li Chen](https://scholariq.org/researchers/li-chen/) - [Zengwu Wang](https://scholariq.org/researchers/zengwu-wang/) - [Weibo Xia](https://scholariq.org/researchers/weibo-xia/) - [Min Shen](https://scholariq.org/researchers/min-shen/) - [Min Yang](https://scholariq.org/researchers/min-yang/) - [Ning Li](https://scholariq.org/researchers/ning-li-3/) - [Xiaoping Xing](https://scholariq.org/researchers/xiaoping-xing/) - [Zhuo Li](https://scholariq.org/researchers/zhuo-li-2/) - [Yan Zhao](https://scholariq.org/researchers/yan-zhao-5/) - [Puyuan Xing](https://scholariq.org/researchers/puyuan-xing/) - [Yujia Li](https://scholariq.org/researchers/yujia-li/) - [Jingcheng Wang](https://scholariq.org/researchers/jingcheng-wang/) - [Ying Li](https://scholariq.org/researchers/ying-li-4/) ## University top topics Showing 8 of 25. - [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/) - [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/) - [Traditional Chinese Medicine Analysis](https://scholariq.org/topics/traditional-chinese-medicine-analysis/) - [Cancer-related molecular mechanisms research](https://scholariq.org/topics/cancer-related-molecular-mechanisms-research/) - [Traditional Chinese Medicine Studies](https://scholariq.org/topics/traditional-chinese-medicine-studies/) - [RNA modifications and cancer](https://scholariq.org/topics/rna-modifications-and-cancer/) - [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/) - [Genomics and Phylogenetic Studies](https://scholariq.org/topics/genomics-and-phylogenetic-studies/) --- Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.